Quantum dots in axillary lymph node mapping: Biodistribution study in healthy mice
Open Access
- 22 April 2008
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 8 (1) , 111
- https://doi.org/10.1186/1471-2407-8-111
Abstract
Background: Breast cancer is the first cause of cancer death among women and its incidence doubled in the last two decades. Several approaches for the treatment of these cancers have been developed. The axillary lymph node dissection (ALND) leads to numerous morbidity complications and is now advantageously replaced by the dissection and the biopsy of the sentinel lymph node. Although this approach has strong advantages, it has its own limitations which are manipulation of radioactive products and possible anaphylactic reactions to the dye. As recently proposed, these limitations could in principle be by-passed if semiconductor nanoparticles (quantum dots or QDs) were used as fluorescent contrast agents for the in vivo imaging of SLN. QDs are fluorescent nanoparticles with unique optical properties like strong resistance to photobleaching, size dependent emission wavelength, large molar extinction coefficient, and good quantum yield. Methods: CdSe/ZnS core/shell QDs emitting around 655 nm were used in our studies. 20 μL of 1 μM (20 pmol) QDs solution were injected subcutaneously in the anterior paw of healthy nude mice and the axillary lymph node (ALN) was identified visually after injection of a blue dye. In vivo fluorescence spectroscopy was performed on ALN before the mice were sacrificed at 5, 15, 30, 60 min and 24 h after QDs injection. ALN and all other organs were removed, cryosectioned and observed in fluorescence microscopy. The organs were then chemically made soluble to extract QDs. Plasmatic, urinary and fecal fluorescence levels were measured. Results: QDs were detected in ALN as soon as 5 min and up to 24 h after the injection. The maximum amount of QDs in the ALN was detected 60 min after the injection and corresponds to 2.42% of the injected dose. Most of the injected QDs remained at the injection site. No QDs were detected in other tissues, plasma, urine and feces. Conclusion: Effective and rapid (few minutes) detection of sentinel lymph node using fluorescent imaging of quantum dots was demonstrated. This work was done using very low doses of injected QDs and the detection was done using a minimally invasive method.Keywords
This publication has 33 references indexed in Scilit:
- On the Benefit of Bivalency in Peptide Ligand/Pin1 InteractionsJournal of Molecular Biology, 2007
- Quantum dot imaging for embryonic stem cellsBMC Biotechnology, 2007
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Migration of Intradermally Injected Quantum Dots to Sentinel Organs in MiceToxicological Sciences, 2007
- Image-Guided Oncologic Surgery Using Invisible Light: Completed Pre-Clinical Development for Sentinel Lymph Node MappingAnnals of Surgical Oncology, 2006
- A Further Validation of Subareolar Injection Technique for Breast Sentinel Lymph Node BiopsyAnnals of Surgical Oncology, 2006
- Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group TrialAnnals of Surgical Oncology, 2006
- Sentinel Lymph Node Mapping of the Gastrointestinal Tract by Using Invisible LightAnnals of Surgical Oncology, 2006
- Lymphatic Drainage of the SkinAnnals of Surgical Oncology, 2004
- Near-infrared fluorescent type II quantum dots for sentinel lymph node mappingNature Biotechnology, 2003